Publications by authors named "Irena Cojbasic"

Claim this Profile
C
Clinical Outcomes of Patients with Chronic Myeloid Leukemia and COVID-19 Infection-A Single Center Survey.
Irena Ćojbašić, Ivana Golubović, Žarko Ćojbašić

Medicina (Kaunas)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of quality of response on survival outcomes among multiple myeloma patients treated with novel agents - a retrospective analysis.
Irena Ćojbašić, Miodrag Vučić, Ivan Tijanić, Žarko Ćojbašić

Sao Paulo Med J· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generic Imatinib in Chronic Myeloid Leukemia Treatment: Long-Term Follow-up.
Irena Ćojbašić, Lana Mačukanović-Golubović, Miodrag Vučić, Žarko Ćojbašić

Clin Lymphoma Myeloma Leuk· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of 6-months of oral ferrous and ferric supplement therapy in patients who were hospitalized for decompensated chronic heart failure.
Snezana Ciric Zdravkovic, Svetlana Petrovic Nagorni, Irena Cojbasic, Vesna Mitic, Predrag Cvetkovic

J Int Med Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of curcumin and PI3K/Akt inhibitor on monosodium glutamate-induced rat thymocytes toxicity.
Miodrag Vucic, Irena Cojbasic, Jelena Vucic, Voja Pavlovic

Gen Physiol Biophys· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The significance of angiogenesis for predicting optimal therapeutic response in chronic myeloid leukaemia patients.
Irena Ćojbašić, Lana Mačukanović-Golubović, Dragan Mihailović, Miodrag Vučić, Žarko Ćojbašić

Pol J Pathol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy.
Irena Ćojbašić, Lana Mačukanović-Golubović, Miodrag Vučić, Ivan Tijanić

Clin Lymphoma Myeloma Leuk· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prediction of clinical outcome in chronic myeloid leukemia.
Irena Ćojbašić, Lana Mačukanović-Golubović, Dragan Mihailović, Miodrag Vučić, Stevo Lukić

Int J Hematol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Factors associated with achievement and durability of cytogenetic response in patients with chronic myeloid leukemia treated with imatinib].
Irena Cojbasić, Lana Macukanović-Golubović

Vojnosanit Pregl· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopathologic and cytogenetic findings in imatinib mesylate treated chronic myelogenous leukemia patients: 2.5 years' experience.
Irena Cojbasić, Lana Macukanović-Golubović

Vojnosanit Pregl· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors associated with complete cytogenetic response in patients with chronic myelogenous leukemia on imatinib mesylate therapy.
Irena Cojbasić, Lana Macukanović-Golubović

Srp Arh Celok Lek· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful treatment of acquired haemophila associated with psoriasis--case report].
Goran Marjanović, Vesna Marjanović, Ljubinka Velicković, Mladen Milenović, Lana Macukanović-Golubović

Srp Arh Celok Lek· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis